74.38
Doximity Inc stock is traded at $74.38, with a volume of 1.21M.
It is up +0.15% in the last 24 hours and up +12.05% over the past month.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
See More
Previous Close:
$74.27
Open:
$72.56
24h Volume:
1.21M
Relative Volume:
0.75
Market Cap:
$10.15B
Revenue:
$550.17M
Net Income/Loss:
$201.35M
P/E Ratio:
74.38
EPS:
1
Net Cash Flow:
$232.07M
1W Performance:
+1.06%
1M Performance:
+12.05%
6M Performance:
+12.58%
1Y Performance:
+77.65%
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
DOCS
Doximity Inc
|
74.38 | 13.91B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
VEEV
Veeva Systems Inc
|
279.93 | 45.56B | 2.97B | 809.93M | 1.33B | 4.87 |
![]()
TEM
Tempus Ai Inc
|
77.33 | 13.76B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
HQY
Healthequity Inc
|
96.16 | 8.12B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
37.09 | 6.45B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
Dec-20-24 | Initiated | Stephens | Equal-Weight |
Dec-04-24 | Initiated | Mizuho | Neutral |
Nov-15-24 | Initiated | Goldman | Neutral |
Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
Aug-09-24 | Upgrade | Needham | Hold → Buy |
Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
Feb-26-24 | Initiated | Leerink Partners | Market Perform |
Jan-03-24 | Initiated | Barclays | Equal Weight |
Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
Aug-09-23 | Downgrade | Needham | Buy → Hold |
Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
Oct-31-22 | Initiated | Wells Fargo | Overweight |
Oct-24-22 | Initiated | Evercore ISI | In-line |
Oct-13-22 | Initiated | BTIG Research | Neutral |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
Sep-07-22 | Initiated | Truist | Hold |
Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
Jul-28-22 | Initiated | Berenberg | Buy |
May-18-22 | Reiterated | BofA Securities | Neutral |
May-18-22 | Reiterated | Goldman | Buy |
May-18-22 | Reiterated | Guggenheim | Buy |
May-18-22 | Reiterated | Jefferies | Buy |
May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
May-18-22 | Reiterated | Needham | Buy |
Apr-07-22 | Initiated | Guggenheim | Buy |
Apr-04-22 | Initiated | BofA Securities | Neutral |
Feb-11-22 | Initiated | Goldman | Buy |
Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
Dec-02-21 | Initiated | Jefferies | Buy |
Nov-17-21 | Initiated | Robert W. Baird | Outperform |
Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
Nov-10-21 | Reiterated | Goldman | Neutral |
Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
Nov-10-21 | Reiterated | Needham | Buy |
Nov-10-21 | Reiterated | Piper Sandler | Overweight |
Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
Jul-19-21 | Initiated | Canaccord Genuity | Buy |
Jul-19-21 | Initiated | Goldman | Neutral |
Jul-19-21 | Initiated | JP Morgan | Overweight |
Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
Jul-19-21 | Initiated | Piper Sandler | Overweight |
Jul-19-21 | Initiated | Raymond James | Outperform |
Jul-19-21 | Initiated | SVB Leerink | Outperform |
Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Doximity, Inc. (DOCS): Among the Health Information Services Stocks Outpacing the Market in 2025 - MSN
Doximity, Inc. $DOCS Shares Sold by Riverbridge Partners LLC - MarketBeat
Strs Ohio Acquires Shares of 11,452 Doximity, Inc. $DOCS - MarketBeat
Do Options Traders Know Something About Doximity Stock We Don't? - sharewise.com
23,793 Shares in Doximity, Inc. $DOCS Purchased by Family Legacy Financial Solutions LLC - MarketBeat
Doximity (NASDAQ:DOCS) Given New $67.00 Price Target at Canaccord Genuity Group - MarketBeat
Hims & Hers Expands Care Ecosystem via Global and Digital Innovation - The Globe and Mail
Financiere des Professionnels Fonds d investissement inc. Takes $320,000 Position in Doximity, Inc. $DOCS - MarketBeat
Voya Investment Management LLC Buys 22,409 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity (NASDAQ:DOCS) Director Regina M. Benjamin Sells 5,000 Shares - MarketBeat
Gallacher Capital Management LLC Buys New Holdings in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. $DOCS Shares Sold by Swedbank AB - MarketBeat
A Decade in Print: The Evolving Academic Benchmark of Cardiology Fellowship Applications - Cureus
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):